Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era

Giuseppe G L Biondi-Zoccai, Giuseppe M. Sangiorgi, Alaide Chieffo, Guido Vittori, Elena Falchetti, Massimo Margheri, Rossella Barbagallo, Corrado Tamburino, Enrico Remigi, Carlo Briguori, Ioannis Iakovou, Pierfrancesco Agostoni, Elephteria Tsagalou, Gloria Melzi, Iassen Michev, Flavio Airoldi, Matteo Montorfano, Mauro Carlino, Antonio Colombo

Research output: Contribution to journalArticlepeer-review

Abstract

Although predictors of acute intraprocedural stent thrombosis (IPST) in the drug-eluting stent era have been proposed, external validation is lacking. We thus analyzed the occurrence of IPST in the RECIPE study and found that, among 1,320 patients who underwent drug-eluting stent implantation, IPST occurred in 6 (0.5%), with in-hospital major adverse events in 4 (67%). IPST was predicted by number and total length of implanted stents, baseline minimal lumen diameter, and, in a pooled analysis that incorporated values from the present study and a previous study, use of elective glycoprotein IIb/IIIa inhibitors. Such results may provide useful information to guide prevention of this complication.

Original languageEnglish
Pages (from-to)1466-1468
Number of pages3
JournalThe American Journal of Cardiology
Volume95
Issue number12
DOIs
Publication statusPublished - Jun 15 2005

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era'. Together they form a unique fingerprint.

Cite this